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Objectives: The ideal cardioplegic alcium (Ca +2) concentration in new- 
borns continues to be debated. Most studies examining cardioplegia 
calcium concentrations have been done with a nonclinical model (i.e., 
isolated heart preparation), the results of which may not be clinically 
applicable, and they have not examined the effect of calcium concentration 
in a clinically relevant stressed (hypoxic) heart. Methods: Twenty neonatal 
piglets 5 to 18 days old were placed on cardiopulmonary b pass, and their 
aortas were crossclamped for 70 minutes with hypocalcemic or normocal- 
cemic multidose blood cardioplegic infusions. Group I (n -- 5; low Ca +2, 0.2 
to 0.4 mmol/L) and group 2 (n = 5; normal Ca ÷2, 1.0 to 1.3 mmol/L) were 
nonhypoxic (uninjured) hearts. Ten other piglets were first ventilated at an 
Fio 2 of 8% to 10% (02 saturation 65% to 70%) for 60 minutes (i.e., causing 
hypoxia) and then reoxygenated at an Fio2 of 100% with cardiopulmonary 
bypass, which produces a clinically relevant stress injury. They then 
underwent cardioplegic arrest (as described above) with a hypocalcemic 
(n = 5, group 3) or normocalcemic (n = 5, group 4) blood cardioplegic 
solution. Myocardial function was assessed with pressure volume loops and 
expressed as a percentage of control values. Coronary vascular esistance 
was measured uring each cardioplegic infusion. All values were reported 
as the mean +- standard error. Results: I n  nonhypoxic hearts (groups 1 and 
2), good myocardial protection was achieved at either concentration of 
cardioplegia calcium, as demonstrated by preservation of postbypass 
systolic function (104% vs 99% end-systolic elastance), minimally increased 
diastolic stiffness (152% vs 162%), no difference in myocardial water (78.9% 
vs 78.9%), and no change in adenosine triphosphate levels or coronary 
vascular esistance. Low-calcium blood cardioplegia solution repaired the 
hypoxic reoxygenation i jury in stressed hearts (group 3), resulting in no 
statistical difference in myocardial function, coronary vascular esistance, 
or adenosine triphosphate l vels compared with nonhypoxic hearts (groups 
I and 2). Conversely, when a normocalcemic cardioplegia solution was used 
in hypoxic hearts (group 4), there was marked reduction in postbypass 
systolic function (49% _ 4% end-systolic elastance; p < 0.05), increased 
diastolic stiffness (276% - 9%; p < 0.05), increased myocardial water 
(80.1% + 0.2%; p < 0.05), rise in coronary vascular esistance (p < 0.05), 
and lower adenosine triphosphate l vels compared with groups 1, 2, and 3. 
Conclusions: This study demonstrates that, in the clinically relevant, intact 
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animal model, good myocardial protection is independent of cardioplegia 
calcium concentration in nonhypoxic (noninjured) hearts; hypoxic 
(stressed) hearts are extremely sensitive to the cardioplegic calcium 
concentration; and normocalcemic ardioplegia is detrimental to neonatal 
myocardiuln subjected to a preoperative hypoxic stress. (J Thorac Cardio- 
vasc Surg 1996;112:1193-201) 
N eonatal myocardial protection remains subopti- mal, resulting in an increased operative mortal- 
ity compared with the results for older children and 
adults. 1-3 In view of the structural, functional, and 
metabolic differences, extrapolation of adult cardio- 
protective strategies to the neonate is fundamentally 
imprudent and potentially harmful. 1-6 Myocardial 
protective strategies and cardioplegia solutions must 
be studied in the infant heart if this problem is to be 
overcome and the results are to be clinically appli- 
cable. 
An important consideration regarding myocardial 
protection is calcium concentration, because high lev- 
els have been implicated as a major component in 
cellular injury during ischemia and reperfusion. 2' 7, s 
Although hypocalcemic cardioplegic solutions are su- 
perior for protecting adult hearts, the ideal cardiople- 
gia calcium concentration i newborns continue to be 
debated.2, 3  8 Most studies examining cardioplegic cal- 
cium concentrations in pediatric hearts were per- 
formed using an isolated heart preparation, which 
does not mimic clinical conditions. In addition, these 
studies examined only normal neonatal hearts, al- 
though many newborn hearts are altered by pre- 
operative stresses such as hypoxia. We therefore 
investigated the appropriate cardioplegic calcium con- 
centration using a model that mimics the clinical 
conditions of nonhypoxic (noninjured) and hypoxic 
(stressed) neonatal hearts. 
Materials and methods 
Twenty neonatal, 5- to 18-day-old piglets (3.5 to 5 kg) 
were premedicated with 40 mg/kg ketamine hydrochloride 
intramuscularly and anesthetized with 30 mg/kg pentobar- 
bital intraperitoneally, followed by 5 mg/kg intravenously 
each hour. The lungs were ventilated through a tracheot- 
omy with a volume ventilator (Servo 900B, Siemens/ 
Elema, Solna, Sweden). All animals received humane care 
in compliance with the "Principles of Laboratory Animal 
Care" formulated by the National Society for Medical 
Research and the "Guide for the Care and Use of 
Laboratory Animals" prepared by the National Academy 
of Sciences and published by the National Institutes of 
Health (NIH publication o. 80023, revised 1978). 
The femoral artery and vein were cannulated to moni- 
tor arterial pressure, for blood gas determinations, and for 
intravenous infusions. After left thorocotomy, the coro- 
nary sinus was cannulated for blood sampling and pres- 
sure monitoring of the ligated hemizygous vein. The heart 
was exposed by means of median sternotomy, and trans- 
ducer-tip catheters (Millar Instruments Inc., Houston, 
Tex.) were placed into the left ventricle, thoracic aorta 
(through the internal mammary), left atrium, and pulmo- 
nary artery. The signals were routed to a recorder (model 
4586C, Hewlett-Packard, Palo Alto, Calif.) by means of 
signal conditioners (model 8805C, Hewlett-Packard). An 
eight-electrode-equipped con uctance atheter (Webster 
Laboratories, Baldwin Park, Calif.) was inserted through 
the left ventricular apex, and the signals were routed to a 
Sigma-5 dual-field signal conditioner processor (Leycon, 
Cardiodynamics, Leiden, Netherlands). After systemic 
heparin administration (3 mg/kg), a thin-walled venous 
cannula (18F) and an aortic cannula (8F) were inserted 
into the right atrial appendage and left subclavian artery, 
respectively. An 18-gauge cardioplegia needle (DLP, Inc., 
Grand Rapids, Mich.) was inserted into the aorta for 
delivery of cardioplegic solutions. Arterial blood gases, 
electrolytes, and hemoglobin (Blood Gas System 288, 
Ciba Corning, Medfield, Mass.) were measured every 15 
minutes to ensure optimal evels. A heating blanket was 
placed below the piglet, and a heating pad was placed on 
the abdomen to maintain acontinuously monitored rectal 
temperature of 37 ° C to 38 ° C. All external heat sources 
were discontinued uring systemic ooling. 
The cardiopulmonary b pass (CPB) circuit was prepared 
with heparin, primed with packed red blood cells from donor 
pigs, and made normocalcemic with CaC12. The hematocrit 
value was adjusted to 25% to 35% with 0.9% normal saline 
(Baxter Healthcare, Deerfield, Ill.). A Shiley Plexus mem- 
brane oxygenator (Shiley Corporation, Irvine, Calif.), was 
used, and the aortic pressure was maintained between 30 and 
50 mm Hg by adjustment of the systemic flow to approxi- 
mately 100 ml/kg/min. 
Cardioplegia protocol. Cardioplegia solutions (CAPS 
Service, Research Medical Inc., Salt Lake City, Utah) are 
shown in Tables I and II. The aorta was crossclamped for 
70 minutes and cardioplegia delivered by using a protocol 
of 5 minutes of warm (37 ° C) followed by 5 minutes of 
cold (4 ° C) blood cardioplegic nduction, a 2-minute cold 
(4 ° C) cardioplegic infusion every 20 minutes, and a 
4-minute warm (37 ° C) cardioplegic reperfusate ("hot 
shot") before aortic unclamping. Cardioplegia was infused 
at a continuously measured aortic pressure of 40 to 50 mm 
Hg. Immediately after crossclamping the aorta, all piglets 
were cooled to a systemic temperature of 25 ° C, and 
rewarming to 37°C was begun 16 minutes before un- 
clamping. CPB was discontinued 30 minutes after aortic 
unclamping, and final functional and biochemical mea- 
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Table I. Low-calcium, warm blood cardioplegic 
solution 
Cardioplegic Volume Component Concentration 
additive added (ml) modified delivered* 
KC1 (2 meq/ml) 10 K + 8-10 mEq/L 
Tham (0.3 mol/L) 225 pH pH 7.5-7.6 
CPD 225 Ca +3 0.2-0.3 mmol/L 
Aspartate/glutamate 250 Substrate 13 mmol/L each 
Ds0W 40 Glucose >400 mg/dl 
DsW 200 Osmolarity 380-400 mOsm 
Tharn, Tromethamine; CPD, citrate-phosphate-dextrose; Ds W, 50% dex- 
trose in water. 
*When mixed in 4:1 ratio with blood. For normocalcemic cardioplegia, 
CaC1 zwas added to make the ionized Ca +2, 1.1 to 1.3/zmol/L when mixed 
in a 4:1 ratio with blood. 
surements were made 30 minutes later, after arterial 
blood gases and the levels of Ca +2 and K ÷ were normal- 
ized. 
Physiological measurements. Coronary vascular esis- 
tance was determined during each cardioplegic nfusion by 
measuring coronary sinus pressure and cardioplegic flow 
after a constant infusion rate with an aortic pressure between 
40 and 50 mm Hg was achieved. Coronary vascular esis- 
tance was calculated with the following formula: 
CIP - CSP 
CVR (dynes- sec 1. cm- 5) = Cardioplegia flow × 80 
In the equation CIP is cardioplegia nfusion pressure, CSP 
is coronary sinus pressure, and CVR is coronary vascular 
resistance. 
Myocardial performance. Left ventricular (LV) pressure 
and conductance atheter signals were amplified and digi- 
tized to inscribe LV pressure volume loops after first cor- 
recting for parallel conductance (myocardial tissue and 
blood viscosity) with hypertonic saline solution according to 
the method of Baan. 9A series of pressure volume loops was 
generated under various conditions by transient occlusion of 
the inferior vena cava during an 8-second apnea. Measure- 
ments were made before hypoxia or bypass (i.e., control) and 
30 minutes after CPB was discontinued. 
The end-systolic pressure-volume relationship, end-di- 
astolic pressure-volume r lationship, and the preload 
recruitable stroke relationship were analyzed with the use 
of a computer graphics program (Spectrum, Bowman- 
Gray School of Medicine, N.C.), on a 33 mHz 486 Dell 
personal computer. LV systolic performance was deter- 
mined from the descending slope of the end-systolic 
pressure-volume relationship by linear egression analysis 
and designated as the end-systolic elastance. End diastolic 
compliance was determined from the exponential regres- 
sion of the end-diastolic pressure-volume r lationship. 
Global myocardial performance was assessed by preload 
recruitable stroke work, which was calculated as the 
integral of left ventricular t ansmural pressure and cavity 
volume over each cardiac ycle. Functional measurements 
are expressed as percent recovery of baseline values, with 
each piglet acting as its own control. After final hemody- 
namic measurements were made, all piglets were placed 
Table II. Low-calcium, cold blood cardioplegic 
solution 
Cardioplegic Volume Component Concentration 
additive added (ml) modified delivered* 
KCI (2 mEq/ml) 10 K + 8-10 mEq/L 
Tham (0.3 mmol/L) 200 pH pH 7.6-7.8 
CPD 50 Ca +2 0.5-0.6 mmol/L 
DsW 1/4 NS 550 Osmolarity 340-360 mOsm 
Tham, Tromethamine; CPD, citrate-phosphate-dextrose; Ds W,, 50% dex- 
trose in water; NS, normal saline. 
*When mixed in 4:1 ratio with blood. For normocalcemic cardioplegia, 
CaC12 was added to make the ionized Ca +2, ].1 to 1.3/xmol/L when mixed 
in a 4:1 ratio with blood. 
back on bypass and cooled to 25 ° C. Hearts were then 
arrested with cold (4 ° C) blood cardioplegia, nd trans- 
mural LV biopsy specimens were obtained. Endocardial 
and epicardial portions were separated, frozen quickly in 
liquid nitrogen, and stored for biochemical analysis. A 
separate sample was obtained for myocardial water. 
Biochemical analysis. Samples were crushed in a liquid 
nitrogen-cooled mortar and pestle and lyophilized (Sa- 
vant Speed Vac Systems, Farmingdale, N.Y.). The aden- 
osine pool was determined according to the method of 
Sarin and colleagues. ~° Ten to 15 mg of dry tissue was 
extracted with 0.6 mol/L perchloric acid, the protein-free 
supernatant eutralized by a mixture of KHCO 3 in 0.5 
mol/L Tris buffer (pH 7.5), and a neutralized solution 
allowed to stand at 4 ° C to precipitate KCLO 4. Aliquots of 
the neutralized extract were chromotographed with high- 
performance liquid chromatograph (Waters Inc., Milford, 
Mass.), equipped with a Waters Nova-Pak column. The 
adenosine pool was isocratically eluted with a mobile 
phase consisting of 0.1 mol/L ammonium phosphate (5.0 
nmol/L) (tetrabutylammonium hydroxide pH 5.0) and 
detected at 233 nm. ATP levels were expressed as micro- 
grams per gram of dry tissue. 
Myocardial water. Ventricular samples were placed in 
a preweighed vial and dried to a constant weight at a 
temperature of 85 ° C. Myocardial water was calculated 
with the following formula: 
Wet weight - Dry weight 
% Myocardial water = × 100 
Wet weight 
Experimental groups 
Nonhypoxemic (uninjured) studies. Five minutes after 
initiating CPB, 10 piglets underwent 70 minutes of car- 
dioplegic arrest by the cardioplegia protocol outlined 
above. Group 1 (n = 5, low calcium) used the hypocalce- 
mic cardioplegic solutions hown in Tables I and II, and in 
group 2 (n = 5, normal calcium) CaCL 2 was added to 
these solutions to make the cardioplegic onized calcium 
concentration normal (1.1 to 1.3 tzmol/L) when mixed 
with blood in a 4:1 ratio. 
Hypoxemic (stress) studies. Ten other piglets underwent 
60 minutes of ventilator hypoxia by lowering the fraction 
of inspired oxygen (Fio2) to 8% to 10%, producing an 
arterial Po2 of 25 to 35 mm Hg and an oxygen saturation 
of 65% to 70%. Before hypoxemia was initiated, piglets 
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Fig. 1. Left ventricular systolic function as measured by 
end-systolic elastance and expressed as a percentage of
control. There is complete preservation of systolic func- 
tion independent of cardioplegic calcium concentration in 
noninjured (nonhypoxic) hearts. In hypoxic hearts low- 
calcium blood cardioplegia solution allows cellular epair 
of the hypoxic reoxygenation injury, with complete return 
of systolic function. In contrast, here is diminished sys- 
tolic function in hypoxic hearts protected with a normo- 
calcemic (NL) cardioplegia solution. *p < 0.05. 
were transfused as necessary to increase their hematocrit 
levels to greater than 35%. This simulates the chronic 
adaptive change of erythrocytosis that occurs in the cyanotic 
infant and increases oxygen-carrying capacity, thereby allow- 
ing ischemia to be avoided during hypoxia. All piglets 
remained hemodynamically stable during the entire 60 min- 
utes of ventilator hypoxia. At the end of 60 minutes, all 
piglets were placed on CPB at an Fioa of 100% for 5 minutes 
to produce a reoxygenation i jury. The aorta was cross- 
clamped, and the heart underwent 70 minutes of cardiople- 
gic arrest with the cardioplegic protocol previously outlined, 
with a hypocalcemic (group 3, n = 5) or normocalcemic 
(group 4, n = 5) cardioplegic solution. 
Statistics. Data were analyzed with use of JMP V2.0 
(SAS Institute, Inc., Cary, N.C.) on a Macintosh IIVX 
computer (Apple Inc, Cupertino, Calif.). A paired Stu- 
dent's t test was used for comparison of variables among 
experimental groups at a probability level of p < 0.05. 
Group data are expressed as the mean _+ standard error of 
the mean. 
Results 
There was no difference between groups for con- 
trol values of LV contractility, diastolic ompliance, 
or global myocardial function. Hypoxia resulted in 
an increase in heart rate from 130 to 150 to a rate of 
190 to 220 beats/rain, decreased systemic vascular 
resistance, increased pulmonary vascular esistance, 
and did not significantly affect cardiac output. All 
piglets tolerated 60 minutes of hypoxia with stable 
hemodynamics. 
Hemodynamic and physiologic measurements. 
Results are depicted in Figs. 1 through 4. There was 
300, 
200, 
Stiffness 
(% Control) 
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0 
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Fig. 2. Left ventricular diastolic compliance as measured 
by the end-diastolic pressure-volume r lationship and 
expressed as a percentage of stiffness compared with 
control determinations. There is only a minimal increase 
in diastolic stiffness in noninjured hearts independent of
cardioplegia calcium concentration. In hypoxic hearts 
hypocalcemic blood cardioplegia solution allows cellular 
repair of the hypoxic reoxygenation injury, resulting in 
only a mild increase in diastolic stiffness, which is not 
statistically different from noninjured hearts. Conversely, 
there was a marked increase in diastolic stiffness in 
hypoxic hearts protected with a normocalcemic (NL) 
cardioplegic solution. *p < 0.05. 
no change or difference in the x intercept (V0) for 
end-systolic elastance or preload recruitable stroke 
work between before (control) and after bypass 
values for any experimental group. Therefore, end- 
systolic elastance, preload recruitable stroke work, 
and diastolic ompliance are expressed as changes in 
slope compared with control measurements. The 
nonhypoxic hearts (group 1 and 2) had complete 
preservation of myocardial function with either con- 
centration of cardioplegic calcium (see Figs. 1 
through 3). Hypoxia followed by reoxygenation pro- 
duces an injury that results in myocardial depres- 
sion.11, 12 A hypocalcemic cardioplegic solution fa- 
cilitated cellular epair of the hypoxic reoxygenation 
injury (group 3), resulting in complete preservation 
of normal postbypass myocardial function (see Figs. 
1 through 3). Conversely, when a normocalcemic 
cardioplegic solution was used in hypoxic hearts 
(group 4), there was marked reduction in systolic, 
diastolic, and global myocardial function (see Figs. 1 
through 3), implying cellular damage. Similarly, 
there were no significant differences in CVR among 
groups 1, 2, and 3 (see Fig. 4) during cardioplegic 
infusions. In contrast, there was a marked increase 
in CVR with each cardioplegic infusion in hypoxic 
hearts protected with a normocalcemic cardioplegic 
solution (group 4). Because these hearts underwent 
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the same hypoxic stress as group 3, this finding 
implies a vascular injury. 
Tissue studies. Results are summarized in Table 
III. Although the levels were slightly lower than 
laboratory control values, there was no difference in 
endocardial ATP levels among groups 1, 2, and 3. 
Endocardial ATP levels were the lowest in hypoxic 
hearts protected with a normocalcemic solution 
(group 4). The ATP/ADP ratio, which reflects the 
ability of mitochondria to phosphorylate ADP to 
ATP, was markedly reduced in hypoxic hearts pro- 
tected with normocalcemic cardioplegia (group 4), 
suggesting mitochondrial damage. Group 4 also had 
the highest percentage ofmyocardial water, indicat- 
ing the greatest degree of cellular injury of any 
group. 
Discussion 
This study demonstrates that, in a clinically rele- 
vant intact animal model simulating conditions in 
the operating room, good myocardial protection is
independent of the cardioplegic calcium concentra- 
tion in nonhypoxic hearts; hypoxic neonatal hearts 
are more sensitive to cardioplegic calcium concen- 
tration; normocalcemic cardioplegia solutions are 
detrimental to hearts subjected to preischemic hy- 
poxia; and the optimal method of myocardial pro- 
tection of hypoxic hearts is achieved with a hypocal- 
cemic cardioplegia solution. 
Intracellular accumulation fcalcium during isch- 
emia and reperfusion has been associated with 
cellular injury. 2' 7, 8, 13, 14 Several mechanisms of in- 
jury have been proposed, which include increased 
ATP use through activation of calcium-dependent 
ATPases; impaired ATP synthesis because of mito- 
chondrial calcium uptake; activation of numerous 
calcium-dependent degradative nzymes such as 
proteases, lipases, and phospholipases; and en- 
hancement by calcium of various free radical medi- 
ated reactions. 13' 14 The neonatal heart may be more 
susceptible to a calcium-mediated cellular injury 
because the sarcoplasmic reticulum of the immature 
myocardium possesses a diminished capacity to se- 
quester calcium and because of different character- 
istics of the calcium transport system. 2' 14 
Although many studies have demonstrated the 
beneficial effects of hypocaicemic cardioplegia solu- 
tions in protecting the adult myocardium, the opti- 
mal cardioplegic calcium concentration i  neonatal 
hearts continues to be debated. 2' 3, 8 The groups of 
Caspi 15 and Kofsky 16 demonstrated better ecovery 
of postischemic myocardial function with hypocalce- 
100 
% Recove~ 
0 
Cardloplegla Ca ÷z Conc. L~w NL 
Non-Hypoxic  
I 
Low NL 
Hypoxic 
/ 
Fig. 3. Overall eft ventricular myocardial function as 
measured by preload recruitable stroke work and ex- 
pressed as a percentage of control. There is complete 
preservation f global myocardial function independent of 
cardioplegia c lcium concentration in noninjured (nonhy- 
poxic) hearts. In hypoxic hearts hypocalcemic cardioplegia 
solution allowed cellular epair of the hypoxic reoxygen- 
ation injury, with complete preservation f global myocar- 
dial function. In contrast, global myocardial function is 
depressed in hypoxic hearts protected with a normocalce- 
mic (NL) cardioplegia solution, indicating cellular dam- 
age. *p < 0.05. 
mic cardioplegic solutions, but those of Pearl 17 and 
Corno 18 found better ecovery with normocalcemic 
solutions. These seemingly conflicting results may 
reflect several factors. Most neonatal studies have 
been conducted with an isolated heart model. Al- 
though this allows precise experimental control, it 
does not mimic the clinical conditions in the oper- 
ating room. For instance, bronchial blood return 
and noncoronary collateral flow are absent in the 
isolated heart preparation, but they may have a 
profound effect in the invivo model. 7 Cardioplegic 
magnesium concentrations may also be responsible 
for differences, because magnesium competes with 
calcium at entry points on the cell membrane. 2' 8 
The optimal calcium concentration determined for a 
solution containing magnesium ay be different if 
magnesium is omitted. 2 Despite the prevalence in 
the pediatric population of preoperative stresses 
such as hypoxia, almost no previous studies have 
included stressed hearts in their investigations. 
However, hypoxia may profoundly alter the neona- 
tal myocardium, influencing the effects of cardiople- 
gic solutions. 2' 3. 11, 12 We therefore xamined iffer- 
ent cardioplegic calcium Concentrations in neonatal 
hearts using a model that mimics conditions of the 
operating room, without added magnesium, and in 
noninjured and hypoxic hearts. 
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Fig. 4. Coronary vascular esistance (CVR) measured uring each cardioplegic infusion. Cardioplegia 
infusions 1 and 4 were during warm (37 ° C) induction and reperfusion, respectively, and 2 and 3 were 
during cold (4 ° C) multidose infusions. There is no difference in CVR in noninjured (nonhypoxic) hearts 
independent of cardioplegia calcium concentration, indicating that both solutions preserve vascular 
endothelial cell function. In hypoxic hearts, ahypocalcemic blood cardioplegia solution resulted in CVRs 
that were similar to nonhypoxic hearts, indicating avoidance of a vascular injury. Conversely, there was a 
marked rise in CVR when a normocalCemic (NL) cardioplegic solution was infused in hypoxic hearts, 
indicating that high calcium caused a vascular injury. *p < 0.05. 
Table III. Endocardial tissue results 
Group ATP  (ixg/gm tissue) ATP/ADP ratio Myocardial water (%) 
Laboratory control 
NL heart/low Ca +2 (group 1) 
NL heart/NL Ca +2 (group 2) 
Hypoxic heart/low Ca +a (group 3) 
Hypoxic heart/NL Ca ÷2 (group 4) 
19.1 -+ 0.6 4.5 _+ 0.2 77.3 -- 0.3 
15.7 +- 0.4 4.3 -+ 0.3 78.9 + 0.4 
15:4 +_ 1.9 4.2 -+ 0.5 78.9 ± 0.1 
15.2 -+ 1.1 4.1 -+ 0.2 79.6 -- 0.6 
12.2 -+ 0.9* 2.3 -+ 0.2t 80.1 + 0.2:) 
NL heart, Normal (noninjured) heart; NL Ca +2, normocalcemic cardioplegia. 
*p < 0.05, group 4 compared with group 1. 
?p < 0.05, group 4 compared with group 1, 2, or 3. 
~p < 0.05 group 4 compared with group 1 or 2. 
In nonhypoxic hearts, there was complete preser- 
vation of myocardial function with either cardiople- 
gic calcium concentration (see Figs. 1 through 3). 
There was also no change in CVR (see Fig. 4), 
myocardial edema, or ATP levels, indicating that 
both levels of cardioplegic alcium provide similar 
protection. However, the ischemic (crossclamp) 
time was relatively short in this study, and the 
neonatal myocardium is more tolerant of ischemia 
than that of the adult, z' 3 Because the reperfusion 
injury depends on the duration of ischemia, these 
factors may have accounted for the lack of differ- 
ence between the two groups. Moreover, congenital 
lesions seen in clinical practice usually result in 
hypoxia or a pressure-volume overload, and there- 
fore "normal" hearts are probably uncommon in the 
neonatal population. 3 
Increasing numbers of infants with cyanotic on- 
genital heart disease are undergoing primary repair. 
Although this may be preferable to palliation, it 
subjects the immature hypoxic heart to CPB and 
high levels of oxygen, which can cause an unin- 
tended reoxygenation injury. TM 12, 19, 2o This injury is 
mediated by oxygen free radicals, results in myocar- 
dial depression, and may explain why impairment of 
ventricular function is common after apparently 
satisfactory surgical correction of cyanotic ongeni- 
tal defects. 1'3, 21, 22 Despite the prevalence of this 
condition, no studies have investigated the effects of 
cardioplegic calcium concentrations in this clinically 
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relevant hypoxic model: Including stressed hearts in 
any investigation of cardioplegia solutions is impor- 
tant because the results may be dramatically altered. 
This is why adult studies imposed a preischemic 
stress when examining cardioplegia solutions. 7 Be- 
cause pediatric hearts rarely undergo preoperative 
ischemia, the injury must be changed to reflect a 
clinically relevant stress, such as hypoxia. 
Subjecting the neonatal heart to hypoxia pro- 
foundly altered the effect different cardioplegia cal- 
cium concentrations had on the myocardium. Hy- 
pocalcemic cardioplegic solutions protected the 
heart from further damage, and they facilitated 
repair of the injury caused by hypoxia nd reoxygen- 
ation; resulting in complete preservation of myocar- 
dial and vascular endothelial cell function (see Figs. 
1 through 4). Conversely, hypoxia followed by reoxy- 
genation altered the myocardium, resulting in an 
increased cellular injury when normocalcemic solu- 
tions were used. This injury was manifested by 
depression in postbypass myocardial and endothe- 
lial cell function. These findings are not surprising, 
because a similar phenomenon occurred when adult 
hearts were subjected to ischemic stress. 7 Although 
our model of acute hypoxia does not allow for the 
chronic adaptive changes that may occur in cyanotic 
newborns, several studies have documented a simi- 
lar oxygen-mediated injury with reoxygenation of 
the chronically hypoxic infant. 3' 19, 2o In addition, 
this sensitivity to cardioplegic solutions after acute 
hypoxia parallels the findings in cyanotic infants and 
chronically hypoxi c animals, I' 2. 23-25 leading us to 
believe these experimental findings are clinically 
relevant. 
Vascular endothelial cell function was determined 
by measuring CVR during each cardioplegic infu- 
sion when the heart was arrested and the flow and 
infusion pressure were constant. Although the myo- 
cardial metabolic demands and CVR may change 
between warm and cold cardioplegia, they should be 
identical for each heart at any given temperature. 
Because our experimental model of hypoxia does 
not result in ischemia, restoration of normoxemic 
perfusion (reoxygenation) should also result in sim- 
ilar CVR in both groups of hypoxic hearts. In 
contrast, there was a marked increase in CVR 
during each cardioplegic infusion in hypoxic hearts 
protected with a normocalcemic solution (group 4). 
The only other reason for this increased CVR would 
be vascular compression from increased myocardial 
water. However, because dema was the same in 
both hypoxic groups, the increased CVR during 
cardioplegic infusions appears to reflect a derange- 
ment in vascular function secondary to the higher 
cardioplegic alcium concentration. This increased 
CVR may have resulted in a less homogeneous 
cardioplegia distribution, compromising myocardial 
protection during the 70 minutes of myocardial 
arrest. We did not measure vascular function after 
discontinuing the bypass. However, because myocar- 
dial function was still depressed after bypass in 
hypoxic hearts protected with a normocalcemic so- 
lution, it is likely that vascular function was similarly 
affected. 
Calcium homeostasis i maintained by several 
ATP-dependent mechanisms. Unlike ischemia, our 
model of acute experimental hypoxia with or with- 
out reoxygenation does not significantly deplete 
ATP levels (unpublished ata). The increased sus- 
ceptibility of hypoxic hearts to high cardioplegic 
calcium therefore must depend on a mechanism 
other than depleted ATP. After cardioplegic arrest, 
the endocardial ATP levels were lowest in hypoxic 
hearts receiving normocalcemic cardioplegic solu- 
tion (group 4). However, the ATP levels were not 
statistically different from hypoxic hearts receiving 
low-calcium cardioplegic solution, despite de- 
creased ventricular function in the normocalcemic 
group. Conversely, when the ATP/ADP ratio was 
examined, it was found to be markedly reduced in 
group 4. This seems to indicate that there is some 
calcium-mediated mitochondrial damage resulting 
in a decreased ability to convert ADP to ATP. 
However, this cannot be proved with our data, 
because we did not directly examine mitochondrial 
function. 
During ischemia, an elevated calcium level accel- 
erates the breakdown of ATP by activation of 
calcium-dependent ATPases. This energy depletion 
may further impair ATP-dependent mechanisms 
that maintain calcium homeostasis. Our experimen- 
tal model of hypoxia does not cause significant 
depletion of nucleotide stores, but chronically cya- 
notic hearts are predisposed to accelerated eple- 
tion of these high-energy compounds during the 
periods of increased myocardial oxygenation de- 
mand associated with exercise or ischemia induced 
during operative repair. 3' 26, 27 Therefore the effects 
of a normocalcemic cardioplegia solution may be 
even more pronounced in the cyanotic infant. 
This study, conducted with a clinically relevant 
model, demonstrates that high and low cardioplegic 
calcium concentrations provide good myocardial 
protection in nonhypoxic hearts subjected to short 
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ischemic intervals. Conversely , when the heart is 
subjected to a preoperative hypoxic stress, car- 
dioplegic alcium concentration takes on increased 
importance, with hypocalcemic solutions providing 
markedly superior myocardial protection. This study 
suggests that, because cyanotic hearts are often 
depressed after apparently successful surgical re- 
pair, hypocalcemic cardioplegic solutions hould al- 
ways be used in cyanotic infants. 
We gratefully acknowledge Ms. Peggy Burse and Ms. 
Kym Montecinos for their organizational and secretarial 
assistance. 
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Discuss ion 
Dr. John H. Kennedy (Cambridge, England). I enjoyed 
your presentation very much. It is a sophisticated study 
and well worked out. 
The leaching of calcium from the presumably normo- 
The Journal of Thoracic and 
Cardiovascular Surgery 
Volume 112, Number 5 
Bolling et al. 1 2 0 1 
calcemic heart is biphasic. The first rapid clearance is from 
the extracellular space, and the slower phase is the cytosol 
and later the mitochondrial portions. Can you tell us what 
the pH was, because that phenomenon is pH dependent 
and theoretically could explain the difference in the two 
groups, unless they were both the same pH. 
Dr. Boiling. Because the cardioplegia in both groups 
had the same pH, it could not have accounted for the 
differences. In addition, the calcium movements you have 
described occur with active myocardial contraction, but 
hearts in this study were exposed to different calcium 
concentrations only during cardioplegic arrest. 
Dr. Jakob Vinten-Johansen (Winston-Salem, N.C.). 
What is the mechanism of postischemic dysfunction in 
the hypoxic hearts? Did you take any other measure- 
ments of injury--creatine kinase activity, for example? 
You concluded that the increase in postischemic vascu- 
lar resistance in the hypoxic normocalcemic cardiople- 
gia group resulted from endothelial dysfunction. Did 
you measure ndothelial function in vivo or in vitro to 
confirm this? 
Dr. Boiling. Calcium is detrimental to ischemic cells, 
because it activates proteases and increases ATP use. We 
believe that high-calcium cardioplegia damages the myo- 
cardium by both of these mechanisms. Several investiga- 
tors have also demonstrated that hypoxic hearts are more 
sensitive to ischemic injury and to ATP depletion, making 
them more vulnerable to calcium. Besides the physico- 
logic measurements, we did examine tissue ATP levels 
and myocardial edema, and both findings support the 
presence of increased cellular injury in the high-calcium 
cardioplegia group. With regard to the changes in vascular 
resistance, we did not examine the coronary artery in 
vitro. Therefore, we can only say that there was a vascular 
injury but cannot be sure of the site of this injury. 
Although we believe that the injury involves the vascular 
endothelial cell, this cannot be proved with this study's 
data. 
